← Evidence map

ReviewHuman vaccines & immunotherapeutics2024

Clinical development of SpikoGen®, an Advax-CpG55.2 adjuvanted recombinant spike protein vaccine.

Nikolai PetrovskyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38839044